| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |